ArticleMolecular pharmacology2021

TP53 Null Mutations Identify Lung Cancer Cell Lines with Highest Sensitivity to the Nontaxane Microtubule Inhibitor Eribulin.

Trista K Hinz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.